Research Paper Volume 16, Issue 2 pp 1733—1749
Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma
Figure 5. Relationship between methylation levels of CpG sites in the HPSM and FDA drug sensitivity.